AAPL325.90-0.70 (-0.21%) ▼|ABBV255.44+2.06 (+0.81%) ▲|ABT101.56-0.10 (-0.10%) ▼|ACN142.90-1.83 (-1.26%) ▼|ADBE229.06-5.68 (-2.42%) ▼|AMAT560.93+35.23 (+6.70%) ▲|AMD525.38+21.81 (+4.33%) ▲|AMGN367.54+3.37 (+0.93%) ▲|AMT164.90-2.16 (-1.29%) ▼|AMZN247.17-2.82 (-1.13%) ▼|AVGO382.16+4.00 (+1.06%) ▲|AXP351.94+0.01 (+0.00%) ▲|BA210.80+1.32 (+0.63%) ▲|BAC60.79+0.37 (+0.61%) ▲|BKNG178.79-0.66 (-0.37%) ▼|BLK1,059.56+5.45 (+0.52%) ▲|BMY60.53+0.37 (+0.62%) ▲|BNY158.42+1.49 (+0.95%) ▲|BRK-B490.08-1.17 (-0.24%) ▼|C131.93+3.21 (+2.49%) ▲|CAT881.98+17.68 (+2.05%) ▲|CL91.04-0.90 (-0.97%) ▼|CMCSA23.82+0.04 (+0.15%) ▲|COF205.51-1.26 (-0.61%) ▼|COP116.63+0.95 (+0.82%) ▲|COST930.60-5.20 (-0.56%) ▼|CRM170.78-3.01 (-1.73%) ▼|CSCO111.78+1.08 (+0.98%) ▲|CVS109.00+1.39 (+1.29%) ▲|CVX190.10+0.39 (+0.21%) ▲|DE585.12-0.89 (-0.15%) ▼|DHR175.59-25.53 (-12.69%) ▼|DIS96.29-0.12 (-0.12%) ▼|DUK125.15-0.70 (-0.56%) ▼|EMR137.79+1.21 (+0.89%) ▲|FDX314.98+8.76 (+2.86%) ▲|GD372.84+2.24 (+0.60%) ▲|GE344.68+3.38 (+0.99%) ▲|GEV1,085.71+6.53 (+0.61%) ▲|GILD132.48-0.73 (-0.55%) ▼|GM78.65+2.85 (+3.76%) ▲|GOOG348.71-2.66 (-0.76%) ▼|GOOGL349.30-2.69 (-0.76%) ▼|GS1,079.21+24.18 (+2.29%) ▲|HD329.22-3.82 (-1.15%) ▼|HON229.48+3.30 (+1.46%) ▲|IBM210.63-2.37 (-1.11%) ▼|INTC102.63+5.57 (+5.74%) ▲|INTU289.31-4.51 (-1.54%) ▼|ISRG361.07+7.90 (+2.24%) ▲|JNJ250.09+1.27 (+0.51%) ▲|JPM342.90+4.03 (+1.19%) ▲|KO81.86-0.27 (-0.32%) ▼|LIN508.76-3.29 (-0.64%) ▼|LLY1,162.73+15.83 (+1.38%) ▲|LMT504.54-5.00 (-0.98%) ▼|LOW202.62-2.09 (-1.02%) ▼|LRCX317.36+10.60 (+3.45%) ▲|MA542.28-5.16 (-0.94%) ▼|MCD264.86-2.78 (-1.04%) ▼|MDLZ59.50-0.77 (-1.28%) ▼|MDT82.86-0.43 (-0.52%) ▼|META647.09+1.24 (+0.19%) ▲|MMM174.64+15.53 (+9.76%) ▲|MO73.85-0.81 (-1.08%) ▼|MRK126.02+1.62 (+1.30%) ▲|MS215.71+4.77 (+2.26%) ▲|MSFT400.11-2.18 (-0.54%) ▼|MU924.05+58.59 (+6.77%) ▲|NEE87.87-0.13 (-0.14%) ▼|NFLX67.68+0.08 (+0.12%) ▲|NKE43.10-0.38 (-0.86%) ▼|NOW103.09-1.61 (-1.54%) ▼|NVDA205.21+1.93 (+0.95%) ▲|ORCL125.23+3.85 (+3.17%) ▲|PEP134.73-0.73 (-0.54%) ▼|PFE24.95+0.20 (+0.81%) ▲|PG147.75-1.38 (-0.93%) ▼|PLTR133.72-1.13 (-0.84%) ▼|PM191.29-1.43 (-0.74%) ▼|QCOM171.95+1.63 (+0.96%) ▲|RTX196.69+2.25 (+1.16%) ▲|SBUX104.78-0.04 (-0.03%) ▼|SCHW102.79+0.25 (+0.24%) ▲|SO93.71-0.76 (-0.80%) ▼|SPG229.40+1.21 (+0.53%) ▲|T22.01+0.06 (+0.25%) ▲|TMO519.19-7.04 (-1.34%) ▼|TMUS192.53-3.11 (-1.59%) ▼|TSLA381.19+11.62 (+3.14%) ▲|TXN291.73+7.66 (+2.69%) ▲|UBER71.95-0.23 (-0.31%) ▼|UNH432.29+10.74 (+2.55%) ▲|UNP294.88-1.37 (-0.46%) ▼|UPS115.44+2.29 (+2.02%) ▲|USB63.16+0.02 (+0.02%) ▲|V357.72-2.85 (-0.79%) ▼|VZ43.35-0.15 (-0.34%) ▼|WFC86.94+0.61 (+0.71%) ▲|WMT111.17-1.03 (-0.92%) ▼|XOM150.40+2.04 (+1.37%) ▲|AAPL325.90-0.70 (-0.21%) ▼|ABBV255.44+2.06 (+0.81%) ▲|ABT101.56-0.10 (-0.10%) ▼|ACN142.90-1.83 (-1.26%) ▼|ADBE229.06-5.68 (-2.42%) ▼|AMAT560.93+35.23 (+6.70%) ▲|AMD525.38+21.81 (+4.33%) ▲|AMGN367.54+3.37 (+0.93%) ▲|AMT164.90-2.16 (-1.29%) ▼|AMZN247.17-2.82 (-1.13%) ▼|AVGO382.16+4.00 (+1.06%) ▲|AXP351.94+0.01 (+0.00%) ▲|BA210.80+1.32 (+0.63%) ▲|BAC60.79+0.37 (+0.61%) ▲|BKNG178.79-0.66 (-0.37%) ▼|BLK1,059.56+5.45 (+0.52%) ▲|BMY60.53+0.37 (+0.62%) ▲|BNY158.42+1.49 (+0.95%) ▲|BRK-B490.08-1.17 (-0.24%) ▼|C131.93+3.21 (+2.49%) ▲|CAT881.98+17.68 (+2.05%) ▲|CL91.04-0.90 (-0.97%) ▼|CMCSA23.82+0.04 (+0.15%) ▲|COF205.51-1.26 (-0.61%) ▼|COP116.63+0.95 (+0.82%) ▲|COST930.60-5.20 (-0.56%) ▼|CRM170.78-3.01 (-1.73%) ▼|CSCO111.78+1.08 (+0.98%) ▲|CVS109.00+1.39 (+1.29%) ▲|CVX190.10+0.39 (+0.21%) ▲|DE585.12-0.89 (-0.15%) ▼|DHR175.59-25.53 (-12.69%) ▼|DIS96.29-0.12 (-0.12%) ▼|DUK125.15-0.70 (-0.56%) ▼|EMR137.79+1.21 (+0.89%) ▲|FDX314.98+8.76 (+2.86%) ▲|GD372.84+2.24 (+0.60%) ▲|GE344.68+3.38 (+0.99%) ▲|GEV1,085.71+6.53 (+0.61%) ▲|GILD132.48-0.73 (-0.55%) ▼|GM78.65+2.85 (+3.76%) ▲|GOOG348.71-2.66 (-0.76%) ▼|GOOGL349.30-2.69 (-0.76%) ▼|GS1,079.21+24.18 (+2.29%) ▲|HD329.22-3.82 (-1.15%) ▼|HON229.48+3.30 (+1.46%) ▲|IBM210.63-2.37 (-1.11%) ▼|INTC102.63+5.57 (+5.74%) ▲|INTU289.31-4.51 (-1.54%) ▼|ISRG361.07+7.90 (+2.24%) ▲|JNJ250.09+1.27 (+0.51%) ▲|JPM342.90+4.03 (+1.19%) ▲|KO81.86-0.27 (-0.32%) ▼|LIN508.76-3.29 (-0.64%) ▼|LLY1,162.73+15.83 (+1.38%) ▲|LMT504.54-5.00 (-0.98%) ▼|LOW202.62-2.09 (-1.02%) ▼|LRCX317.36+10.60 (+3.45%) ▲|MA542.28-5.16 (-0.94%) ▼|MCD264.86-2.78 (-1.04%) ▼|MDLZ59.50-0.77 (-1.28%) ▼|MDT82.86-0.43 (-0.52%) ▼|META647.09+1.24 (+0.19%) ▲|MMM174.64+15.53 (+9.76%) ▲|MO73.85-0.81 (-1.08%) ▼|MRK126.02+1.62 (+1.30%) ▲|MS215.71+4.77 (+2.26%) ▲|MSFT400.11-2.18 (-0.54%) ▼|MU924.05+58.59 (+6.77%) ▲|NEE87.87-0.13 (-0.14%) ▼|NFLX67.68+0.08 (+0.12%) ▲|NKE43.10-0.38 (-0.86%) ▼|NOW103.09-1.61 (-1.54%) ▼|NVDA205.21+1.93 (+0.95%) ▲|ORCL125.23+3.85 (+3.17%) ▲|PEP134.73-0.73 (-0.54%) ▼|PFE24.95+0.20 (+0.81%) ▲|PG147.75-1.38 (-0.93%) ▼|PLTR133.72-1.13 (-0.84%) ▼|PM191.29-1.43 (-0.74%) ▼|QCOM171.95+1.63 (+0.96%) ▲|RTX196.69+2.25 (+1.16%) ▲|SBUX104.78-0.04 (-0.03%) ▼|SCHW102.79+0.25 (+0.24%) ▲|SO93.71-0.76 (-0.80%) ▼|SPG229.40+1.21 (+0.53%) ▲|T22.01+0.06 (+0.25%) ▲|TMO519.19-7.04 (-1.34%) ▼|TMUS192.53-3.11 (-1.59%) ▼|TSLA381.19+11.62 (+3.14%) ▲|TXN291.73+7.66 (+2.69%) ▲|UBER71.95-0.23 (-0.31%) ▼|UNH432.29+10.74 (+2.55%) ▲|UNP294.88-1.37 (-0.46%) ▼|UPS115.44+2.29 (+2.02%) ▲|USB63.16+0.02 (+0.02%) ▲|V357.72-2.85 (-0.79%) ▼|VZ43.35-0.15 (-0.34%) ▼|WFC86.94+0.61 (+0.71%) ▲|WMT111.17-1.03 (-0.92%) ▼|XOM150.40+2.04 (+1.37%) ▲|
23.6 C
New York
Tuesday, July 21, 2026

Tag: bloodstream

newssourceFORcompanyinformationcontent1releasesmarket

Citius Oncology Expands Distribution Network for LYMPHIR with Execution of Distribution Services Agreement with Cencora

Agreement with global pharmaceutical solutions provider enhances commercial infrastructure and reinforces launch readiness for FDA-approved immunotherapy LYMPHIR™ CRANFORD, N.J., July 15, 2025 /PRNewswire/ -- Citius...

MAP Medical Partners with Metrix-Secure

CHICAGO, July 14, 2025 /PRNewswire/ -- MAP Medical has confirmed a new partnership with Metrix-Secure, becoming an officially authorized distributor for the nationally acclaimed, industry-leading...

QNET Unveils Wellness Breakthroughs and Global Empowerment at V-Malaysia 2025

Over 8,000 global entrepreneurs gather in Penang for five days of wellness innovation and mentorship. HONG KONG, July 11, 2025 /PRNewswire/ -- QNET kicked off...

Citius Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement

CRANFORD, N.J.  , July 8, 2025 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius Pharma" or the "Company") (Nasdaq: CTXR) today announced that it has received...

Best THCA Vape of 2025 – Area 52 Named #1 Disposable by Oregon Observer

THCA Vapes Dominate Premium Cannabis Market as Area 52 Named Best THCA Vape of 2025 
THCA Vapes Dominate Premium Cannabis Market as Area 52 Named Best THCA Vape of 2025

JUICE PLUS LAUNCHES SUPERFOOD POWDER: A POWERHOUSE OF PLANT-BASED NUTRITION IN EVERY SIP

 Rated as having a 'Superior Taste'* with scientifically proven nutrients, and a rainbow of plant powders from 30 different fruits, vegetables, and berries in...

Spectral Medical Inc. Announces Filing of Base Shelf Prospectus

TORONTO, July 04, 2025 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today announced that it has filed a preliminary short form base shelf prospectus with the securities regulatory authorities in each of the provinces of Canada, except Québec (the “Securities Regulators”).

Nasal COVID Vax Shows Promise in Phase 1 Clinical Trial

CINCINNATI, July 4, 2025 /PRNewswire/ -- During the COVID-19 pandemic, scientists learned that the critical path to infection started with the SARS-CoV-2 virus invading...

Snow Caps THCA Flower – Extra Frosty Exotic Cannabis Strains Now Available for Sale

Las Vegas, NV, July 03, 2025 (GLOBE NEWSWIRE) -- Area 52, a vanguard in cannabinoid science and botanical engineering, today announced the debut of its 2025 THCA Snow Caps collection, a groundbreaking line of premium hemp flower completely enveloped in pure THCA diamonds. Engineered to “Alienize Your Mind,” these crystalline-coated buds represent a new frontier in potency and sensory experience for the discerning cannabis connoisseur.

Quebec implements public reimbursement of Pluvicto® – a defining milestone for radioligand therapy in Canada

Pluvicto® now publicly funded in provinces covering most Canadians, offering renewed hope to those facing progressive PSMA-positive metastatic castration-resistant prostate cancer Momentum builds nationwide as...

GPCR-Targeting Therapies Market Poised for Strong Growth During the Forecast Period (2025-2034) Across 7MM Due to the Rising Cancer Diagnoses and Drug Pipeline Expansion...

The GPCR-targeting therapies market is expected to grow significantly in the coming years. This is due to the increasing number of patients who are...

GPCR-Targeting Therapies Market Poised for Strong Growth During the Forecast Period (2025-2034) Across 7MM Due to the Rising Cancer Diagnoses and Drug Pipeline Expansion...

The GPCR-targeting therapies market is expected to grow significantly in the coming years. This is due to the increasing number of patients who are...

Rarecells, Inc. Appoints Dr. Rita Shaknovich to Scientific Advisory Board

Rarecells, a leader in liquid biopsy technology, appoints Dr. Rita Shaknovich to its Scientific Advisory Board.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsBloodstream

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers